Senti Biosciences Stock Total Debt
| SNTI Stock | USD 2.28 0.02 0.88% |
Senti Biosciences fundamentals help investors to digest information that contributes to Senti Biosciences' financial success or failures. It also enables traders to predict the movement of Senti Stock. The fundamental analysis module provides a way to measure Senti Biosciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Senti Biosciences stock.
The Senti Biosciences' current Total Debt To Capitalization is estimated to increase to 0.38. Senti | Total Debt |
Senti Biosciences Company Total Debt Analysis
Senti Biosciences' Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Current Senti Biosciences Total Debt | 37.67 M |
Most of Senti Biosciences' fundamental indicators, such as Total Debt, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Senti Biosciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Senti Total Debt Driver Correlations
Understanding the fundamental principles of building solid financial models for Senti Biosciences is extremely important. It helps to project a fair market value of Senti Stock properly, considering its historical fundamentals such as Total Debt. Since Senti Biosciences' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Senti Biosciences' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Senti Biosciences' interrelated accounts and indicators.
Click cells to compare fundamentals
Senti Total Debt Historical Pattern
Today, most investors in Senti Biosciences Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Senti Biosciences' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's total debt growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Senti Biosciences total debt as a starting point in their analysis.
Senti Biosciences Total Debt |
| Timeline |
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
| Competition |
Senti Net Debt
Net Debt |
|
Based on the latest financial disclosure, Senti Biosciences has a Total Debt of 37.67 M. This is 98.63% lower than that of the Biotechnology sector and 88.4% lower than that of the Health Care industry. The total debt for all United States stocks is 99.29% higher than that of the company.
Senti Total Debt Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Senti Biosciences' direct or indirect competition against its Total Debt to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Senti Biosciences could also be used in its relative valuation, which is a method of valuing Senti Biosciences by comparing valuation metrics of similar companies.Senti Biosciences is currently under evaluation in total debt category among its peers.
Senti Biosciences ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Senti Biosciences' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Senti Biosciences' managers, analysts, and investors.Environmental | Governance | Social |
Senti Biosciences Institutional Holders
Institutional Holdings refers to the ownership stake in Senti Biosciences that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Senti Biosciences' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Senti Biosciences' value.| Shares | Tower Research Capital Llc | 2024-03-31 | 8.5 K | Morgan Stanley - Brokerage Accounts | 2024-03-31 | 1.6 K | Wolverine Asset Management Llc | 2024-03-31 | 800 | Bank Of America Corp | 2024-03-31 | 241 | Wells Fargo & Co | 2024-06-30 | 0.0 | Comerica Bank | 2024-06-30 | 0.0 | The Toronto-dominion Bank | 2024-06-30 | 0.0 | Bridgeway Capital Management, Llc | 2024-06-30 | 0.0 | Millennium Management Llc | 2024-06-30 | 0.0 | Nea Management Company, Llc | 2024-03-31 | 4.4 M | Ark Investment Management Llc | 2024-03-31 | 1.6 M |
Senti Fundamentals
| Return On Equity | -1.11 | ||||
| Return On Asset | -0.33 | ||||
| Operating Margin | (180.17) % | ||||
| Current Valuation | 30.23 M | ||||
| Shares Outstanding | 4.58 M | ||||
| Shares Owned By Insiders | 21.00 % | ||||
| Shares Owned By Institutions | 22.70 % | ||||
| Number Of Shares Shorted | 69.36 K | ||||
| Price To Book | 0.23 X | ||||
| Price To Sales | 30.62 X | ||||
| Revenue | 2.56 M | ||||
| Gross Profit | (29.78 M) | ||||
| EBITDA | (61.52 M) | ||||
| Net Income | (83.41 M) | ||||
| Cash And Equivalents | 140.78 M | ||||
| Cash Per Share | 3.24 X | ||||
| Total Debt | 37.67 M | ||||
| Debt To Equity | 0.20 % | ||||
| Current Ratio | 8.09 X | ||||
| Book Value Per Share | 9.65 X | ||||
| Cash Flow From Operations | (52.4 M) | ||||
| Short Ratio | 3.95 X | ||||
| Earnings Per Share | (17.54) X | ||||
| Target Price | 6.0 | ||||
| Number Of Employees | 48 | ||||
| Beta | 2.76 | ||||
| Market Capitalization | 10.35 M | ||||
| Total Asset | 119.48 M | ||||
| Retained Earnings | (244.34 M) | ||||
| Working Capital | 58.53 M | ||||
| Current Asset | 7.4 M | ||||
| Current Liabilities | 1.05 M | ||||
| Net Asset | 119.48 M |
About Senti Biosciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Senti Biosciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Senti Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Senti Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| MSFT | Microsoft | |
| V | Visa Class A | |
| MSFT | Microsoft | |
| BAC | Bank of America | |
| CRM | Salesforce |
Check out Senti Biosciences Piotroski F Score and Senti Biosciences Altman Z Score analysis. For more detail on how to invest in Senti Stock please use our How to Invest in Senti Biosciences guide.You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Senti Biosciences. If investors know Senti will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Senti Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (17.54) | Revenue Per Share 0.075 | Quarterly Revenue Growth (1.00) | Return On Assets (0.33) | Return On Equity (1.11) |
The market value of Senti Biosciences is measured differently than its book value, which is the value of Senti that is recorded on the company's balance sheet. Investors also form their own opinion of Senti Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Senti Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Senti Biosciences' market value can be influenced by many factors that don't directly affect Senti Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Senti Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Senti Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Senti Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.